Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Goldenwell Biotech (GWLL) Asset Utilization Ratio (2020 - 2025)

Goldenwell Biotech (GWLL) has disclosed Asset Utilization Ratio for 6 consecutive years, with 0.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Asset Utilization Ratio fell 122.84% year-over-year to 0.0, compared with a TTM value of 0.0 through Sep 2025, down 122.84%, and an annual FY2024 reading of 0.0, down 92.02% over the prior year.
  • Asset Utilization Ratio was 0.0 for Q3 2025 at Goldenwell Biotech, up from 0.0 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.2 in Q2 2023 and bottomed at 0.01 in Q3 2023.
  • Average Asset Utilization Ratio over 5 years is 0.05, with a median of 0.0 recorded in 2024.
  • The sharpest move saw Asset Utilization Ratio skyrocketed 290646.03% in 2022, then plummeted 122.84% in 2025.
  • Year by year, Asset Utilization Ratio stood at 0.03 in 2021, then skyrocketed by 403.57% to 0.17 in 2022, then tumbled by 93.36% to 0.01 in 2023, then crashed by 93.89% to 0.0 in 2024, then plummeted by 197.26% to 0.0 in 2025.
  • Business Quant data shows Asset Utilization Ratio for GWLL at 0.0 in Q3 2025, 0.0 in Q2 2025, and 0.0 in Q1 2025.